Outcome | Unadjusted Risk Rural Hospital % [95% CI] | Unadjusted Risk Urban Hospital % [95% CI] | Unadjusted OR [95% CI] | Unadjusted OR p-value | Adjusted OR* [95% CI] | Adjusted OR p-value | |
---|---|---|---|---|---|---|---|
All-cause in-hospital mortality | Choledocholithiasis | 0.5 [0.4–0.6] | 0.5 [0.5–0.6] | 0.99 [0.79–1.24] | 0.92 | 1.24 [0.94–1.64] | 0.13 |
Cholangitis | 1.7 [1.1–2.2] | 1.7 [1.5–1.9] | 1.01 [0.71–1.45] | 0.94 | 1.15 [0.74–1.80] | 0.54 | |
Any intervention Δ | Choledocholithiasis | 77.5 [76.5–78.5] | 90.9 [90.7–91.1] | 2.90 [2.72–3.10] | < 0.00001 | 2.94 [2.72–3.17] | < 0.00001 |
Cholangitis | 27.8 [25.0–30.6] | 55.0 [54.1–55.9] | 3.17 [2.75–3.66] | < 0.00001 | 2.97 [2.50–3.54] | < 0.00001 | |
Any surgical intervention | Choledocholithiasis | 59.3 [58.2–60.5] | 58.4 [57.9–58.8] | 0.96 [0.91–1.01] | 0.12 | 0.96 [0.91–1.02] | 0.24 |
Cholangitis | 6.7 [5.5–7.8] | 7.3 [6.9–7.7] | 1.10 [0.91–1.35] | 0.32 | 1.12 [0.89–1.41] | 0.34 | |
Any radiologic intervention | Choledocholithiasis | 0.7 [0.5–0.8] | 1.9 [1.8–2.0] | 2.90 [2.35–3.58] | < 0.00001 | 2.79 [2.20–3.54] | < 0.00001 |
Cholangitis | 1.0 [0.5–1.4] | 6.5 [6.1–7.0] | 7.26 [4.53–11.63] | < 0.00001 | 5.78 [3.43–9.74] | < 0.00001 | |
Any endoscopic intervention | Choledocholithiasis | 44.8 [43.0–46.7] | 75.3 [74.9–75.6] | 3.75 [3.47–4.05] | < 0.00001 | 3.61 [3.33–3.94] | < 0.00001 |
Cholangitis | 23.8 [21.1–26.5] | 47.8 [46.8–48.8] | 2.93 [2.51–3.43] | < 0.00001 | 2.79 [2.32–3.36] | < 0.00001 | |
Any post-intervention adverse event | Choledocholithiasis | 14.4 [13.8–15.1] | 15.3 [15.1–15.5] | 1.07 [1.01–1.13] | 0.019 | 1.10 [1.03–1.18] | 0.0047 |
Cholangitis | 33.8 [29.5–38.1] | 35.4 [34.4–36.4] | 1.07 [0.88–1.30] | 0.49 | 1.01 [0.80–1.28] | 0.94 | |
Any post-operative complication adverse event | Choledocholithiasis | 14.9 [14.1–15.6] | 15.9 [15.6–16.1] | 1.08 [1.01–1.15] | 0.021 | 1.14 [1.05–1.23] | < 0.001 |
Cholangitis | 40.3 [31.1–49.5] | 45.2 [42.6–47.9] | 1.22 [0.82–1.82] | 0.32 | 1.10 [0.68–1.77] | 0.70 | |
Any post-radiologic complication adverse event | Choledocholithiasis | 28.1 [19.3–36.9] | 33.1 [31.4–34.9] | 1.27 [0.82–1.98] | 0.29 | 1.37 [0.84–2.23] | 0.21 |
Cholangitis | 59.7 [39.7–79.7] | 47.7 [44.7–50.7] | 0.62 [0.27–1.42] | 0.26 | 0.76 [0.28–2.09] | 0.60 | |
Any post-endoscopic complication adverse event | Choledocholithiasis | 14.1 [13.2–15.0] | 15.1 [14.9–15.4] | 1.09 [1.01–1.17] | 0.028 | 1.15 [1.05–1.26] | 0.0022 |
Cholangitis | 32.5 [27.9–37.1] | 33.8 [32.8–34.9] | 1.06 [0.86–1.32] | 0.57 | 1.03 [0.80–1.34] | 0.79 | |
Any post-intervention mortality | Choledocholithiasis | 0.5 [0.4–0.6] | 0.5 [0.5–0.5] | 1.00 [0.77–1.29] | 0.97 | 1.10 [0.81–1.50] | 0.55 |
Cholangitis | 1.5 [0.5–2.5] | 1.5 [1.3–1.8] | 1.01 [0.51–1.99] | 0.98 | 2.02 [0.71–5.70] | 0.19 | |
Post-operative mortality | Choledocholithiasis | 0.4 [0.3–0.6] | 0.5 [0.4–0.5] | 1.05 [0.77–1.45] | 0.75 | 1.19 [0.81–1.74] | 0.38 |
Cholangitis | 2.9 [0.1–5.7] | 1.9 [1.2–2.6] | 0.66 [0.22–1.94] | 0.45 | 4.33 [0.57–32.90] | 0.16 | |
Post-radiologic mortality | Choledocholithiasis | 4.3 [0.6–8.0] | 2.6 [2.0–3.2] | 0.60 [0.24–1.52] | 0.28 | 0.65 [0.22–1.86] | 0.42 |
Cholangitis | 8.8 [0.0–20.2]* | 3.4 [2.4–4.5] | 0.37 [0.09–1.62] | 0.19 | 0.92 [0.12–7.20] | 0.94 | |
Post-endoscopic mortality | Choledocholithiasis | 0.5 [0.3–0.6] | 0.4 [0.4–0.5] | 0.87 [0.62–1.22] | 0.41 | 0.90 [0.62–1.33] | 0.61 |
Cholangitis | 1.4 [0.4–2.4] | 1.4 [1.1–1.6] | 0.99 [0.46–2.14] | 0.98 | 2.05 [0.61–6.85] | 0.24 |